Walleye Capital’s Tectonic Therapeutic TECX Stock Holding History

Walleye Capital’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-73,517	Closed	-$3.39M	–	5294
2024 Q4	$3.39M	Buy	73,517 +555	+0.8%	+$23.5K	0.01%	1343
2024 Q3	$2.21M	Buy	72,962 +48,978	+204%	+$895K	﹤0.01%	1848
2024 Q2	$395K	Buy	23,984 +12,680	+112%	+$203K	﹤0.01%	3704
2024 Q1	$174K	Buy	+11,304	New	+$179K	﹤0.01%	4069
2022 Q2	–	Sell	-16,577	Closed	-$263K	–	2766
2022 Q1	$263K	Buy	16,577 +4,480	+37%	+$92.6K	0.01%	1384
2021 Q4	$559K	Buy	12,097 +2,191	+22%	+$126K	0.02%	919
2021 Q3	$663	Buy	+9,906	New	+$813K	0.02%	657

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Walleye Capital's TECX Position: Q1 2025 in Review

Walleye Capital sold out of Tectonic Therapeutic (TECX) in Q1 2025, closing a stake of 73,517 shares — an estimated $3.39M sold.

Walleye Capital first reported a position in TECX in Q3 2021 and held it in 7 quarters. The position peaked at $3.39M in Q4 2024. 78 funds tracked by Wall St. Rank hold TECX as of Q1 2025.

Walleye Capital reported no remaining Tectonic Therapeutic position as of Q1 2025 after selling out during the quarter.
Walleye Capital sold 73,517 Tectonic Therapeutic shares in Q1 2025, an estimated $3.39M.
Walleye Capital first reported a position in Tectonic Therapeutic in Q3 2021 and held it in 7 quarters.
Walleye Capital's Tectonic Therapeutic position peaked at $3.39M in Q4 2024.
78 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2025.

Based on Walleye Capital's 13F filing for Q1 2025, filed 14 May 2025.